President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices they will be negotiating this year. These negotiations come after President ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations. The list includes Botox and the GLP-1 drug Trulicity. The negotiations stem from ...

Feb 11 (Reuters) - AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for ‌Medicare & Medicaid Services to impose price controls for Botox ...

The US plans to slash the price it pays for Botox and diabetes drug Trulicity, the latest medicines to be targeted under legislation that’s expected to save the government more than $200 billion over ...

The list covers the top 15 highest spending drugs for Medicare across a variety of serious health conditions. HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug ...